Compensatory changes in Ca(2+) and myocardial O(2) consumption in beta-tropomyosin transgenic hearts

Am J Physiol Heart Circ Physiol. 2001 Dec;281(6):H2539-48. doi: 10.1152/ajpheart.2001.281.6.H2539.

Abstract

Transgenic mice overexpressing beta-tropomyosin have increased myofilament Ca(2+) sensitivity that we hypothesized would result in altered relationships among pressure and heart rates, intracellular Ca(2+), and myocardial O(2) consumption. In perfused hearts from transgenic mice there was a marked negative force-frequency response between 6 and 10 Hz with a 30 +/- 3% reduction in peak-positive first derivative of pressure development over time (dP/dt) compared with 14 +/- 2% in wild-type mice (P < 0.001). At 8 Hz systolic pressures were normal, though peak systolic intracellular Ca(2+) was significantly reduced in transgenic mice versus wild type (726 +/- 61 vs. 936 +/- 67 nM, P < 0.05) indicating an alteration in the pressure-Ca(2+) relationship. Over a wide range of positive and negative inotropic interventions there were normal developed pressures, though marked elevations in myocardial O(2) consumption (15-54%). Because pressures are normal and intracellular Ca(2+) decreased and myocardial O(2) consumption increased, this suggests that these abnormalities are at least in part compensatory mechanisms to the altered myofilament function.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Blood Pressure / physiology
  • Calcium / metabolism*
  • Calcium Signaling / physiology
  • Cardiotonic Agents / pharmacology
  • Dobutamine / pharmacology
  • In Vitro Techniques
  • Male
  • Mice
  • Mice, Transgenic
  • Myocardial Contraction / drug effects
  • Myocardial Contraction / physiology
  • Myocardium / metabolism*
  • Oxygen Consumption / physiology*
  • Perfusion
  • Tropomyosin / genetics*

Substances

  • Cardiotonic Agents
  • Tropomyosin
  • Dobutamine
  • Calcium